ROCHE DIAGNOSTICS LIMITED

Location

Founded

1956-09-14

Risk Signals

24754 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about ROCHE DIAGNOSTICS LIMITED

Live alerts from global media, monitored by Business Radar

Public debt rises 4.7% in August to almost 1.6 trillion euros

2023-10-23 (expansion.com)

Public debt rises 4.7% in August to almost 1.6 trillion euros

The total debt of Public Administrations amounts to 1,563 billion euros in August 2023, with a growth rate of 4.7% in interannual terms compared to

Read more
PTC to sell spinal muscular atrophy drug royalties for $1B

2023-10-19 (biopharmadive.com)

PTC to sell spinal muscular atrophy drug royalties for $1B

A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.

Read more
PTC to sell spinal muscular atrophy drug royalties for $1B

2023-10-19 (biopharmadive.com)

PTC to sell spinal muscular atrophy drug royalties for $1B

A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.

Read more
PTC to sell spinal muscular atrophy drug royalties for $1B

2023-10-19 (biopharmadive.com)

PTC to sell spinal muscular atrophy drug royalties for $1B

A second deal with Royalty Pharma around the Roche therapy Evrysdi will allow PTC to retire Blackstone debt and keep more cash for future operations.

Read more

Never miss a headline about ROCHE DIAGNOSTICS LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages